<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="9509">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    https://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 13, 2016</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00743717</url>
  </required_header>
  <id_info>
    <org_study_id>G010204</org_study_id>
    <nct_id>NCT00743717</nct_id>
  </id_info>
  <brief_title>Evaluation of the Safety and Effectiveness of the Kinamed Gem Ceramic Femoral Component for Total Knee Replacement</brief_title>
  <official_title>Clinical Trial on the Zirconia Femoral Component for the Gem Total Knee System</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kinamed Incorporated</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kinamed Incorporated</source>
  <oversight_info>
    <authority>United States: Food and Drug Administration</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to provide evidence that the safety and effectiveness of the
      ceramic femoral component of the Gem Total Knee System is similar to FDA approved implants
      used in total knee replacement surgery. The hypotheses to be tested are that the
      investigational and control groups are equivalent in terms of patient success rate and
      complication-free rate.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Due to excellent biocompatibility and wear characteristics, ceramics have a long history of
      success in total hip arthroplasty (THA). Use of a ceramic-polyethylene wear couple in total
      knee arthroplasty (TKA) has shown promising laboratory and early clinical results. The use
      of ceramics in this study is intended to address long-term failure of TKA due to osteolysis
      associated with polyethylene wear debris.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2004</start_date>
  <completion_date type="Actual">December 2012</completion_date>
  <primary_completion_date type="Actual">December 2012</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Knee Score at 2 Years Post Operation</measure>
    <time_frame>within 2 years</time_frame>
    <safety_issue>No</safety_issue>
    <description>The criterion used to assess the outcome is a Knee Score (as defined by Knee Society Clinical Rating System) &gt; 80 points at two-years follow-up. This scoring system is defined in the following paper: Insall JN, Dorr LD, Scott RD, and Scott WN (1989). Rationale of the Knee Society clinical rating system. Clin Orthop(248): 13-4. The scale ranges from minimum of 0 (worst) to maximum of 100 (best). Knee Score &gt; 80 was used as a criterion to assess &quot;success&quot;.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">4</enrollment>
  <condition>Knee Osteoarthritis</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>zirconia femoral component</intervention_name>
    <description>total knee arthroplasty performed using implant with zirconia femoral component</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>cobalt chrome femoral component</intervention_name>
    <description>total knee arthroplasty performed using implant with cobalt chrome femoral component</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Skeletally mature

          -  Primary TKA for osteoarthritis or post-traumatic arthritis of the knee joint

          -  Stable or reconstructable collateral and posterior cruciate ligaments

          -  Correctable deformity

          -  Intact quadriceps and hamstrings mechanisms

          -  Patella bone thick enough (at least 15 mm) after resection

        Exclusion Criteria:

          -  Previous TKA

          -  Bilateral knee arthritis

          -  Non-availability for follow-up

          -  Mental incompetence or confinement

          -  Patients being treated with other investigational devices for same disorder

          -  Infection

          -  Osteoporosis, acute renal failure, or other disorders known to affect bone quality

          -  Charcot's or Paget's disease

          -  Patient physical condition preventing use of appropriate size implant

          -  Disease conditions affecting blood supply to knee

          -  Insufficient bone quality or quantity

          -  Physical condition predisposing implant to extreme loads

          -  History of septic knee arthritis

          -  History of drug abuse
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Vineet Sarin, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Kinamed Incorporated</affiliation>
  </overall_official>
  <verification_date>May 2013</verification_date>
  <lastchanged_date>May 21, 2013</lastchanged_date>
  <firstreceived_date>August 27, 2008</firstreceived_date>
  <firstreceived_results_date>February 27, 2013</firstreceived_results_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>total knee arthroplasty</keyword>
  <keyword>osteoarthritis</keyword>
  <keyword>ceramic bearing</keyword>
  <keyword>zirconia</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Osteoarthritis</mesh_term>
    <mesh_term>Osteoarthritis, Knee</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Recruited during pre-op TKA clinical exam during year 2004.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>1: Zirconia Femoral</title>
          <description>zirconia femoral component : total knee arthroplasty performed using implant with zirconia femoral component</description>
        </group>
        <group group_id="P2">
          <title>2: CoCr Femoral</title>
          <description>cobalt chrome femoral component : total knee arthroplasty performed using implant with cobalt chrome femoral component</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>1: Zirconia Femoral</title>
          <description>zirconia femoral component : total knee arthroplasty performed using implant with zirconia femoral component</description>
        </group>
        <group group_id="B2">
          <title>2: CoCr Femoral</title>
          <description>cobalt chrome femoral component : total knee arthroplasty performed using implant with cobalt chrome femoral component</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <measure_list>
        <measure>
          <title>Number of Participants</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="2"/>
                <measurement group_id="B2" value="2"/>
                <measurement group_id="B3" value="4"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>&lt;=18 years</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="0"/>
                <measurement group_id="B2" value="0"/>
                <measurement group_id="B3" value="0"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Between 18 and 65 years</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="1"/>
                <measurement group_id="B2" value="0"/>
                <measurement group_id="B3" value="1"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>&gt;=65 years</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="1"/>
                <measurement group_id="B2" value="2"/>
                <measurement group_id="B3" value="3"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="62.5" spread="13.4"/>
                <measurement group_id="B2" value="65.5" spread="4.94"/>
                <measurement group_id="B3" value="64" spread="8.45"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>Female</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="2"/>
                <measurement group_id="B2" value="1"/>
                <measurement group_id="B3" value="3"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Male</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="0"/>
                <measurement group_id="B2" value="1"/>
                <measurement group_id="B3" value="1"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>United States</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="2"/>
                <measurement group_id="B2" value="2"/>
                <measurement group_id="B3" value="4"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Knee Score at 2 Years Post Operation</title>
        <description>The criterion used to assess the outcome is a Knee Score (as defined by Knee Society Clinical Rating System) &gt; 80 points at two-years follow-up. This scoring system is defined in the following paper: Insall JN, Dorr LD, Scott RD, and Scott WN (1989). Rationale of the Knee Society clinical rating system. Clin Orthop(248): 13-4. The scale ranges from minimum of 0 (worst) to maximum of 100 (best). Knee Score &gt; 80 was used as a criterion to assess &quot;success&quot;.</description>
        <time_frame>within 2 years</time_frame>
        <safety_issue>No</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>1: Zirconia Femoral</title>
            <description>zirconia femoral component : total knee arthroplasty performed using implant with zirconia femoral component</description>
          </group>
          <group group_id="O2">
            <title>2: CoCr Femoral</title>
            <description>cobalt chrome femoral component : total knee arthroplasty performed using implant with cobalt chrome femoral component</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="2"/>
                  <measurement group_id="O2" value="2"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Knee Score at 2 Years Post Operation</title>
            <description>The criterion used to assess the outcome is a Knee Score (as defined by Knee Society Clinical Rating System) &gt; 80 points at two-years follow-up. This scoring system is defined in the following paper: Insall JN, Dorr LD, Scott RD, and Scott WN (1989). Rationale of the Knee Society clinical rating system. Clin Orthop(248): 13-4. The scale ranges from minimum of 0 (worst) to maximum of 100 (best). Knee Score &gt; 80 was used as a criterion to assess &quot;success&quot;.</description>
            <units>units on a scale</units>
            <param>Mean</param>
            <dispersion>Full Range</dispersion>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="91" lower_limit="85" upper_limit="97"/>
                  <measurement group_id="O2" value="89" lower_limit="88" upper_limit="90"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>1: Zirconia Femoral</title>
          <description>zirconia femoral component : total knee arthroplasty performed using implant with zirconia femoral component</description>
        </group>
        <group group_id="E2">
          <title>2: CoCr Femoral</title>
          <description>cobalt chrome femoral component : total knee arthroplasty performed using implant with cobalt chrome femoral component</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Perry Secor</name_or_title>
      <organization>Los Alamitos Orthopaedic Group</organization>
      <phone>805-384-2748</phone>
      <email>vsarin@kinamed.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>
